Author: admin

Metastatic HER2-positive Breast Cancer Market Expected to Experience Major Growth by 2034, According to DelveInsight | Ambrx, Zymeworks/Jazz Pharma, Roche, Criterium, Seagen, Sichuan Baili Pharma,

The Key Metastatic HER2-positive Breast Cancer Companies in the market include – Daiichi Sankyo/AstraZeneca, Roche/Chugai, Seagen, MacroGenics, Ambrx, Zymeworks/Jazz Pharmaceuticals, Taiho Oncology, GeneQuantum Healthcare, Criterium, Inc., Seagen Inc., Sichuan Baili Pharma, BioInvent International AB, and others.

DelveInsight’s “Metastatic HER2-positive Breast Cancer Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Metastatic HER2-positive Breast Cancer, historical and forecasted epidemiology as well as the Metastatic HER2-positive Breast Cancer market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

To Know in detail about the Metastatic HER2-positive Breast Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Metastatic HER2-positive Breast Cancer Market Forecast

 

Some of the key facts of the Metastatic HER2-positive Breast Cancer Market Report: 

  • The Metastatic HER2-positive Breast Cancer market size is anticipated to grow with a significant CAGR during the study period (2020-2034)

  • In January 2024, Processa Pharmaceuticals revealed its intentions to broaden the scope of Next Generation Capecitabine (NGC-Cap) development by including its application in the treatment of advanced or metastatic breast cancer, starting with the forthcoming Phase II trial. NGC-Cap involves the concurrent administration of PCS6422 and low doses of Capecitabine. The company aims to commence the Phase II study in the third quarter of 2024.

  • Anti-HER2 therapies, including HERCEPTIN, PERJETA, KADCYLA, and ENHERTU, have transformed the treatment landscape for HER2-positive cancers, which were once linked to more aggressive disease and worse prognoses.

  • Seagen’s extensive TUKYSA development strategy encompasses a Phase II trial (HER2CLIMB-04) that combines TUKYSA with ENHERTU for second-line treatment of HER2-positive breast cancer, as well as a Phase III trial (HER2CLIMB-05) assessing TUKYSA in combination with HERCEPTIN and Roche’s PERJETA as a first-line maintenance therapy.

  • Estimates indicate that the total number of new HER2-positive breast cancer cases in the seven major markets reached approximately 102,000 in 2023. This figure is anticipated to rise throughout the forecast period from 2024 to 2034.

  • The highest number of HR+/HER2+ breast cancer cases was found in the United States, with approximately 32,000 cases reported.

  • Germany recorded the highest number of HER2-positive breast cancer cases among the EU4 and the UK, with approximately 11,000 cases in 2023, whereas Spain had the fewest cases.

  • In Japan, Stage II had the highest number of HER2-positive breast cancer cases, with approximately 6,000 cases reported in 2023.

  • Key Metastatic HER2-positive Breast Cancer Companies: Daiichi Sankyo/AstraZeneca, Roche/Chugai, Seagen, MacroGenics, Ambrx, Zymeworks/Jazz Pharmaceuticals, Taiho Oncology, GeneQuantum Healthcare, Criterium, Inc., Seagen Inc., Sichuan Baili Pharma, BioInvent International AB, and others

  • Key Metastatic HER2-positive Breast Cancer Therapies: ENHERTU (fam-trastuzumab deruxtecan-nxk), KADCYLA (ado-trastuzumab emtansine), HERCEPTIN HYLECTA, TUKYSA, MARGENZA, ARX788, Zanidatamab, TAS2940, GQ1001, Giredestrant, Alpelisib, Tucatinib, BL-M07D1, BI-1607, and others 

  • The Metastatic HER2-positive Breast Cancer market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Metastatic HER2-positive Breast Cancer pipeline products will significantly revolutionize the Metastatic HER2-positive Breast Cancer market dynamics.

 

Metastatic HER2-positive Breast Cancer Overview

Metastatic HER2-positive breast cancer refers to breast cancer that has spread beyond the breast and nearby lymph nodes to other parts of the body, such as the bones, liver, lungs, or brain, and is characterized by the overexpression of the human epidermal growth factor receptor 2 (HER2) protein. HER2-positive breast cancer tends to be more aggressive than other types of breast cancer.

 

Get a Free sample for the Metastatic HER2-positive Breast Cancer Market Forecast, Size & Share Analysis Report:

https://www.delveinsight.com/report-store/metastatic-her2-positive-breast-cancer-market 

 

Metastatic HER2-positive Breast Cancer Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Metastatic HER2-positive Breast Cancer Epidemiology Segmentation:

The Metastatic HER2-positive Breast Cancer market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

  • Total Prevalence of Metastatic HER2-positive Breast Cancer

  • Prevalent Cases of Metastatic HER2-positive Breast Cancer by severity

  • Gender-specific Prevalence of Metastatic HER2-positive Breast Cancer

  • Diagnosed Cases of Episodic and Chronic Metastatic HER2-positive Breast Cancer

 

Download the report to understand which factors are driving Metastatic HER2-positive Breast Cancer epidemiology trends @ Metastatic HER2-positive Breast Cancer Epidemiology Forecast

 

Metastatic HER2-positive Breast Cancer Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Metastatic HER2-positive Breast Cancer market or expected to get launched during the study period. The analysis covers Metastatic HER2-positive Breast Cancer market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Metastatic HER2-positive Breast Cancer Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Metastatic HER2-positive Breast Cancer Therapies and Key Companies

  • ENHERTU (fam-trastuzumab deruxtecan-nxk): Daiichi Sankyo/AstraZeneca

  • KADCYLA (ado-trastuzumab emtansine): Roche/Chugai

  • HERCEPTIN HYLECTA: Roche

  • TUKYSA: Seagen

  • MARGENZA: MacroGenics

  • ARX788: Ambrx

  • Zanidatamab: Zymeworks/Jazz Pharmaceuticals

  • TAS2940: Taiho Oncology

  • GQ1001: GeneQuantum Healthcare

  • Giredestrant: Roche

  • Alpelisib: Criterium, Inc.

  • Tucatinib: Seagen Inc.

  • BL-M07D1: Sichuan Baili Pharma

  • BI-1607: BioInvent International AB

 

Discover more about therapies set to grab major Metastatic HER2-positive Breast Cancer market share @ Metastatic HER2-positive Breast Cancer Treatment Landscape 

 

Metastatic HER2-positive Breast Cancer Market Drivers

  • Strong uptake of Daiichi/Astra’s ENHERTU in second and third-line metastatic patients, owing to the unprecedented PFS any therapy in later lines could have ever achieved.

  • Therapies for treating patients whose disease is resistant or refractory to prior HER2 treatment can potentially change the market dynamics in later-line settings.

 

Metastatic HER2-positive Breast Cancer Market Barriers

  • As the current landscape of HER2+ is already packed with old aged blockbuster therapies, companies such as Ambrx BioPharma are developing novel therapies, aiming to target ENHERTU treated patients

  • Despite the treatment with ADCs, around 20–30% of patients progress within 12 months, so there can be a significant market opportunity for therapies targeting these patients.

 

Scope of the Metastatic HER2-positive Breast Cancer Market Report

  • Study Period: 2020–2034

  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

  • Key Metastatic HER2-positive Breast Cancer Companies: Daiichi Sankyo/AstraZeneca, Roche/Chugai, Seagen, MacroGenics, Ambrx, Zymeworks/Jazz Pharmaceuticals, Taiho Oncology, GeneQuantum Healthcare, Criterium, Inc., Seagen Inc., Sichuan Baili Pharma, BioInvent International AB, and others

  • Key Metastatic HER2-positive Breast Cancer Therapies: ENHERTU (fam-trastuzumab deruxtecan-nxk), KADCYLA (ado-trastuzumab emtansine), HERCEPTIN HYLECTA, TUKYSA, MARGENZA, ARX788, Zanidatamab, TAS2940, GQ1001, Giredestrant, Alpelisib, Tucatinib, BL-M07D1, BI-1607, and others

  • Metastatic HER2-positive Breast Cancer Therapeutic Assessment: Metastatic HER2-positive Breast Cancer current marketed and Metastatic HER2-positive Breast Cancer emerging therapies

  • Metastatic HER2-positive Breast Cancer Market Dynamics: Metastatic HER2-positive Breast Cancer market drivers and Metastatic HER2-positive Breast Cancer market barriers 

  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

  • Metastatic HER2-positive Breast Cancer Unmet Needs, KOL’s views, Analyst’s views, Metastatic HER2-positive Breast Cancer Market Access and Reimbursement 

 

To know more about Metastatic HER2-positive Breast Cancer companies working in the treatment market, visit @ Metastatic HER2-positive Breast Cancer Clinical Trials and Therapeutic Assessment

 

Table of Contents 

1. Metastatic HER2-positive Breast Cancer Market Report Introduction

2. Executive Summary for Metastatic HER2-positive Breast Cancer

3. SWOT analysis of Metastatic HER2-positive Breast Cancer

4. Metastatic HER2-positive Breast Cancer Patient Share (%) Overview at a Glance

5. Metastatic HER2-positive Breast Cancer Market Overview at a Glance

6. Metastatic HER2-positive Breast Cancer Disease Background and Overview

7. Metastatic HER2-positive Breast Cancer Epidemiology and Patient Population

8. Country-Specific Patient Population of Metastatic HER2-positive Breast Cancer 

9. Metastatic HER2-positive Breast Cancer Current Treatment and Medical Practices

10. Metastatic HER2-positive Breast Cancer Unmet Needs

11. Metastatic HER2-positive Breast Cancer Emerging Therapies

12. Metastatic HER2-positive Breast Cancer Market Outlook

13. Country-Wise Metastatic HER2-positive Breast Cancer Market Analysis (2020–2034)

14. Metastatic HER2-positive Breast Cancer Market Access and Reimbursement of Therapies

15. Metastatic HER2-positive Breast Cancer Market Drivers

16. Metastatic HER2-positive Breast Cancer Market Barriers

17.  Metastatic HER2-positive Breast Cancer Appendix

18. Metastatic HER2-positive Breast Cancer Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

 

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: neva
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Metastatic HER2-positive Breast Cancer Market Expected to Experience Major Growth by 2034, According to DelveInsight | Ambrx, Zymeworks/Jazz Pharma, Roche, Criterium, Seagen, Sichuan Baili Pharma,

Menkes Disease Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Cyprium Therapeutics and Sentynl Therapeutics, Cyprium Therapeutics, Inc.

The Key Menkes Disease Companies in the market inlcude – Cyprium Therapeutics and Sentynl Therapeutics, Cyprium Therapeutics, Inc., and others.

DelveInsight’s “Menkes Disease Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Menkes Disease, historical and forecasted epidemiology as well as the Menkes Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

To Know in detail about the Menkes Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Menkes Disease Market Forecast

 

Some of the key facts of the Menkes Disease Market Report: 

  • The Menkes Disease market size was valued ~USD 8 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)

  • In December 2023, Sentynl Therapeutics, Inc. (Sentynl), a biopharmaceutical company based in the U.S. and fully owned by Zydus Lifesciences, Ltd. (Zydus Group), has announced the signing of an Assignment and Assumption Agreement with Cyprium Therapeutics, Inc. (Cyprium), a subsidiary of Fortress Biotech, Inc. (Nasdaq: FBIO). As part of this agreement, Cyprium has successfully transferred its global proprietary rights and U.S. FDA documentation related to CUTX-101, a copper histidinate candidate for treating Menkes disease, to Sentynl.

  • The Standard of Care accounted for the entire market, which was valued at approximately USD 7.9 million in 2023 across the 7MM.

  • According to our assessment, there were approximately 177 diagnosed prevalent cases of Menkes Disease in the 7MM in 2023, with expectations for these numbers to rise by 2034. The US had the highest number of cases.

  • Among European countries in 2023, France had the highest diagnosed prevalent cases of Menkes Disease at 26%, followed by Germany and the UK, each with 24%. Conversely, Spain had the lowest diagnosed prevalence, accounting for 11%.

  • In 2023, the US represented the largest share of diagnosed Menkes disease cases in the 7MM, with 54%, followed by Japan, which accounted for approximately 11%. Among European countries, France had the highest number of cases, representing about 9% of the total 7MM cases.

  • In 2023, France held the largest market share in the EU4 and UK region with 27%, while Spain had the smallest share at 12%.

  • The 7MM treatment market currently lacks an approved targeted therapy for Menkes Disease. However, with the anticipated launch of CUTX-101 by 2025, the market is expected to see significant growth.

  • Key Menkes Disease Companies: Cyprium Therapeutics and Sentynl Therapeutics, Cyprium Therapeutics, Inc., and others

  • Key Menkes Disease Therapies: CUTX-101, Copper Histidinate, and others

  • The Menkes Disease epidemiology based on gender analyzed that Menkes Disease usually affects male neonates through unaffected carrier women. It may occurs in females, related to unusual genetic circumstances

  • The Menkes Disease market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Menkes Disease pipeline products will significantly revolutionize the Menkes Disease market dynamics.

 

Menkes Disease Overview

Menkes disease is a rare genetic disorder caused by a mutation in the ATP7A gene, which is responsible for copper transport in the body. This condition leads to severe copper deficiency, affecting the body’s ability to utilize copper effectively. Symptoms often appear in infancy and may include poor growth, developmental delays, neurological problems, and distinctive hair abnormalities (often described as “kinky” or “curly” hair). Menkes disease is typically fatal in early childhood without treatment. Management options include copper histidinate injections and supportive care, though outcomes can vary significantly.

 

Get a Free sample for the Menkes Disease Market Report: 

https://www.delveinsight.com/report-store/menkes-disease-market

 

Menkes Disease Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Menkes Disease Epidemiology Segmentation:

The Menkes Disease market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

  • Total Prevalence of Menkes Disease

  • Prevalent Cases of Menkes Disease by severity

  • Gender-specific Prevalence of Menkes Disease

  • Diagnosed Cases of Episodic and Chronic Menkes Disease

 

Download the report to understand which factors are driving Menkes Disease epidemiology trends @ Menkes Disease Epidemiology Forecast

 

Menkes Disease Therapies and Key Companies

  • Copper Histidinate: Cyprium Therapeutics, Inc.

  • CUTX-101: Cyprium Therapeutics and Sentynl Therapeutics

 

Menkes Disease Market Drivers

  • Submission of NDA of CUTX-101

  • Increasing awareness among families who have a history of Menkes

  • Parents of affected babies understand the rarity of the disease and allow their children to be a part of the trial

  • Ongoing development of screening techniques

  • Ongoing development of gene therapy

 

Menkes Disease Market Barriers

  • Clinical challenges in the early diagnosis of disease

  • Inability to trace the carrier mother

  • Insufficient number of studies to estimate the exact number of Menkes patients

  • Insufficient number of researches for the treatment of Menkes disease 

 

Menkes Disease Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Menkes Disease market or expected to get launched during the study period. The analysis covers Menkes Disease market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Menkes Disease Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Discover more about therapies set to grab major Menkes Disease market share @ Menkes Disease Treatment Market

 

Scope of the Menkes Disease Market Report

  • Study Period: 2020–2034

  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

  • Key Menkes Disease Companies: Cyprium Therapeutics and Sentynl Therapeutics, Cyprium Therapeutics, Inc., and others

  • Key Menkes Disease Therapies: CUTX-101, Copper Histidinate, and others

  • Menkes Disease Therapeutic Assessment: Menkes Disease current marketed and Menkes Disease emerging therapies

  • Menkes Disease Market Dynamics: Menkes Disease market drivers and Menkes Disease market barriers 

  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

  • Menkes Disease Unmet Needs, KOL’s views, Analyst’s views, Menkes Disease Market Access and Reimbursement 

 

To know more about Menkes Disease companies working in the treatment market, visit @ Menkes Disease Clinical Trials and Therapeutic Assessment

 

Table of Contents 

1. Menkes Disease Market Report Introduction

2. Executive Summary for Menkes Disease

3. SWOT analysis of Menkes Disease

4. Menkes Disease Patient Share (%) Overview at a Glance

5. Menkes Disease Market Overview at a Glance

6. Menkes Disease Disease Background and Overview

7. Menkes Disease Epidemiology and Patient Population

8. Country-Specific Patient Population of Menkes Disease 

9. Menkes Disease Current Treatment and Medical Practices

10. Menkes Disease Unmet Needs

11. Menkes Disease Emerging Therapies

12. Menkes Disease Market Outlook

13. Country-Wise Menkes Disease Market Analysis (2020–2034)

14. Menkes Disease Market Access and Reimbursement of Therapies

15. Menkes Disease Market Drivers

16. Menkes Disease Market Barriers

17.  Menkes Disease Appendix

18. Menkes Disease Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Menkes Disease Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Cyprium Therapeutics and Sentynl Therapeutics, Cyprium Therapeutics, Inc.

Dietitian Ilene Nasseri Introduces Personalized Program to Empower Women in Overcoming Emotional Eating

Registered Dietitian Ilene Nasseri announces the launch of her personalized 1-on-1 weight loss coaching program. Aimed at helping women overcome binge eating and emotional eating, the program offers custom meal and fitness plans, weekly check-ins, and 24/7 support.

Registered Dietitian Ilene Nasseri, a renowned expert in emotional eating and sustainable weight management, has officially launched her highly anticipated 1-on-1 coaching program. Specifically designed to support women struggling with binge eating and emotional eating, this personalized program provides tailored solutions to help clients regain control of their health and achieve lasting weight loss.

With an extensive social media presence — boasting 261,000 TikTok followers and 121,000 Instagram followers — Nasseri has solidified her position as a trusted authority in the fields of nutrition, weight loss, and emotional eating recovery. Her new coaching program integrates her personal journey with professional expertise, focusing on balance and long-term behavioral change, steering clear of restrictive dieting.

“I know what it’s like to feel trapped in the cycle of emotional eating. Through my own journey and as a dietitian, I’ve learned that sustainable change comes from balance, not restriction,” said Nasseri. “My goal with this program is to help women finally break free from the cycle and regain control of their health in a way that lasts.”

Key Features of Ilene Nasseri’s 1-on-1 Weight Loss Coaching Program:

  • Customized Meal Plans: Tailored to individual dietary needs and preferences for a sustainable, enjoyable approach to nutrition.
  • Personalized Fitness Plans: Designed around each client’s fitness level and preferences, whether for home or gym workouts.
  • Weekly Check-ins: Regular progress reviews to keep clients on track with their goals.
  • 24/7 Support: Direct access to Ilene for guidance, motivation, and support throughout their journey.
  • Community Support Group: A private group for clients to connect, encourage, and hold one another accountable.

Applications for Ilene Nasseri’s 1-on-1 coaching program open on October 21st, and women interested in joining can apply via her website at https://ilenenasnutrition.com.

Addressing a Critical Need

Ilene Nasseri’s program fills a crucial gap in the health and wellness industry by focusing on emotional eating, a key barrier to sustained weight loss. Research highlights that many women face challenges with the emotional aspects of eating. Nasseri’s unique approach combines nutrition and fitness coaching with behavioral and emotional support, empowering women to break free from harmful cycles.

With the support of Rocket Launch Media, a digital marketing agency that has played a pivotal role in expanding her online presence, Nasseri has reached a wider audience. Rocket Launch Media specializes in helping professionals like Nasseri grow their digital platforms and connect with their target audiences.

To learn more about their services, visit https://rocketlaunchmedia.com.

For more information about Ilene Nasseri’s 1-on-1 coaching program, or to apply, visit https://ilenenasnutrition.com.

Media Contact
Company Name: Nas Nutrition RD
Contact Person: Ilene Nasseri
Email: Send Email
Country: United States
Website: https://nasnutritionrd.com/about/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Dietitian Ilene Nasseri Introduces Personalized Program to Empower Women in Overcoming Emotional Eating

Bath Remodeling Contractors in Boca Raton, FL, Focuses on Contemporary Designs and Custom Fixtures

Boca Raton, FL – In the evolving world of home design, the bathroom has become a central focus for innovation and style. At ABC Construction Building, one of the leading bathroom remodeling contractors in Boca Raton, FL, the team is dedicated to redefining bathroom spaces with contemporary designs and custom fixtures that cater to the sophisticated tastes of modern homeowners.

Israel Morag, the company’s seasoned home remodeling contractor in Boca Raton, FL, emphasizes the importance of merging aesthetics with functionality. “Today’s bathrooms are not just about basic functionality; they are about creating a personal sanctuary that aligns with the homeowner’s lifestyle and comfort,” explains Morag. His team works closely with clients to design bathrooms that are not only visually appealing but also equipped with the latest in technology and innovation.

The focus at ABC Construction Building is on customizing every aspect of the bathroom remodel. From luxurious walk-in showers with body sprays to elegant freestanding tubs and smart toilets, the options are limitless. “As bath remodeling in Boca Raton, FL experts, we ensure that each element, from the tiles to the lighting fixtures, is selected to create a cohesive and inviting space,” says Morag.

One of the standout features of ABC Construction’s approach is their use of custom fixtures. Whether it’s a bespoke vanity with integrated sinks or custom cabinetry that maximizes storage without compromising on style, the bathroom remodeling contractors Boca Raton, FL team is skilled at delivering tailored solutions. “Our goal is to make every bathroom we design as unique as the individuals who use them,” Morag adds.

For those considering a bathroom overhaul in Boca Raton, ABC Construction offers unparalleled expertise and innovative design solutions. “Visit https://abcconstructionbuilding.com/ to explore how we can transform your bathroom into a stunning and functional space,” invites Morag. With a commitment to quality craftsmanship and customer satisfaction, ABC Construction remains a top bathroom remodeling contractor in Boca Raton, FL, ensuring that each project reflects the latest trends and personal preferences of their clients.

Media Contact
Company Name: ABC Construction Building | Home builders in Delray Beach, FL
Contact Person: Israel Morag
Email: Send Email
Phone: +1 561-998-5776
Address:112 SE 10th St
City: Delray Beach
State: Florida 33444
Country: United States
Website: https://abcconstructionbuilding.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Bath Remodeling Contractors in Boca Raton, FL, Focuses on Contemporary Designs and Custom Fixtures

Leading Real Estate Agent in Castle Rock, CO Recognized for Excellence with Five Star Award

Castle Rock, CO – Cindy Rein, a leading real estate agent in Castle Rock, CO, has once again solidified her reputation for exceptional service and client satisfaction by securing the Five Star Real Estate Agent award for the fifth consecutive year. This accolade is reserved for agents who exemplify outstanding service and commitment to their clients, and Cindy’s consistent recognition speaks volumes about her dedication to the Castle Rock community.

As a Realtor agent in Castle Rock, CO, Cindy’s approach to real estate is deeply rooted in understanding and addressing the unique needs of each client. Whether navigating first-time homebuyers through the purchasing process or helping seasoned investors maximize their returns, Cindy’s expertise and meticulous attention to detail ensure that all clients receive top-tier guidance. “Winning this award repeatedly reinforces my commitment to my clients and to maintaining the highest standards of service in the industry,” Cindy shares.

The award also highlights Cindy’s profound impact on the local market as a Castle Rock, CO, Realtor. Her strategic advice on getting prequalified, understanding market trends, and avoiding common pitfalls has proven invaluable for countless clients. Cindy emphasizes the importance of working with a knowledgeable agent to navigate the complexities of the real estate market safely and effectively.

Beyond her award-winning service, Cindy’s role as a real estate selling agent in Castle Rock, CO, includes a strong focus on community involvement and ethical practices, which have significantly contributed to her business growth through referrals and repeat clients. “My goal is to not only assist in buying and selling homes but also to build lasting relationships and support the community that has supported me,” Cindy elaborates.

For anyone considering buying or selling in the area, Cindy Rein represents the pinnacle of professionalism and client-focused service. “Visit http://www.sherlockhomes.net/ to partner with a proven leader in the field and experience first-hand the quality of service recognized by the Five Star Real Estate Agent award,” Cindy invites. With Cindy, clients are assured of receiving knowledgeable, award-winning assistance every step of the way.

Media Contact
Company Name: Sherlock Homes | Real Estate Agent in Castle Rock CO
Contact Person: Cindy Rein
Email: Send Email
Phone: +1 720-272-4890
Address:880 W Happy Canyon Rd #120
City: Castle Rock
State: Colorado 80108
Country: United States
Website: http://www.sherlockhomes.net/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Leading Real Estate Agent in Castle Rock, CO Recognized for Excellence with Five Star Award

Mold Remediation in Los Angeles, CA Gains Importance Amid Insurance Market Shifts

The shifting dynamics of the home insurance market in California, particularly with the increase in premiums and regulatory changes, have put a spotlight on the importance of specialized restoration services. Igor Chausovsky, owner of a premier damage restoration company, discusses the growing significance of mold remediation in Los Angeles, CA, especially in light of the evolving insurance policies and climate-related challenges.

“Mold can be a serious issue following water damage, particularly if not addressed promptly and effectively,” Igor explains. With the state’s increased incidence of floods and storms, the demand for professional water damage repair in Los Angeles, CA, has surged. Igor’s company is at the forefront, providing expert assessments and remediation to prevent mold from compromising indoor air quality and structural integrity.

The complexities of insurance coverage for mold damage highlight the need for homeowners to be well-informed about their policies. “As insurers adjust their strategies in response to climate change and rising claims costs, understanding your coverage limits and conditions for water damage restoration in Los Angeles, CA is crucial,” Igor advises. This knowledge is essential for timely and successful insurance claims, particularly when mold is involved, as many policies have specific limitations or exclusions related to mold damage.

Furthermore, Igor’s team offers crawl space repair in Los Angeles, CA, a service increasingly vital for maintaining the health of a home’s structure and its resistance to mold growth. “Keeping your crawl spaces clean and well-maintained is an effective way to mitigate the risk of mold, which is becoming a crucial consideration given the current insurance market shifts,” he adds.

In response to these market changes, homeowners are urged to take proactive steps, including regular inspections and maintenance. For expert guidance and service in mold remediation, visit http://fastfixla.com/. Discover how partnering with Igor Chausovsky and his professional team can provide not only peace of mind but also a strategic advantage in managing your home’s health and compliance with insurance requirements.

Media Contact
Company Name: FastFix Restoration | Damage restoration in Los Angeles, CA
Contact Person: Media Relations
Email: Send Email
Phone: +1 818-688-6288
Address:360 S Burnside Ave.
City: Los Angelels
State: California 90036
Country: United States
Website: http://fastfixla.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Mold Remediation in Los Angeles, CA Gains Importance Amid Insurance Market Shifts

Alion Corporation Unveils +Pocket Custom: The Stylish and Practical Solution for Effortless Bag Organization

“The “+Poket Custom” by Alion Corporation is a versatile add-on designed for backpacks, tote bags, or shoulder bags, offering enhanced storage and usability. It allows easy access to essentials like phones and wallets, combining practicality with style.”
Alion Corporation introduces ‘+Poket Custom,’ a stylish and practical add-on that easily attaches to any bag, making it effortless to access a phone, wallet, and other essentials. Built for durability and convenience, this innovative pocket combines functionality with style for everyday use.

Alion Corporation (Headquarters: Fukuoka, Japan; CEO: Tsuyoshi Yamamoto) will launch the “+Poket Custom” on October 10 2024, targeting the U.S. market through the international crowdfunding platform Kickstarter.

The “+Poket Custom” is a stylish and practical pocket that can be attached to backpacks, tote bags, or shoulder bags to enhance storage capacity and usability.

It was developed to eliminate the hassle of searching through a bag for items like a smartphone, credit card, or car keys when needed in a hurry.

1. Functionality

The “+Poket Custom” is designed to allow easy access to frequently used items such as wallets, smartphones, and transit passes without needing to remove the backpack. The front pocket includes a variety of storage spaces, such as slots for smartphones and passports, pen holders, a large gusseted pocket, zipper pockets, mesh pockets, and a key hook. The strong magnet ensures smooth retrieval of smartphones and passports.

Additionally, the unique design for attaching to backpacks, which is currently under design patent application, features a non-slip shoulder strap and small additional belts with carabiners for enhanced stability. The pocket is made from 940D nylon fabric, known for its water resistance and abrasion resistance, offering 1.7 times the durability of the previous model. Weighing only 170g, it remains comfortable to use even for extended periods.

2. Design

Available in six rich color options—black, khaki, navy, gray, red, and purple—the “+Poket Custom” is versatile enough to suit any setting. When folded, it measures approximately 3 cm in thickness and about 23.5×12.5 cm in size, offering ample storage space despite its compact form.

The “+Poket Custom” can also be used as a detachable pocket bag or as a shoulder bag, making it a practical choice for various activities such as walking the dog, fishing, camping, or traveling.

The “+Poket Custom” will be launched on Kickstarter on October 10, 2024. It will be available at a special limited-time price of $55 (including shipping) with a 25% OFF Super Early Bird discount for the first 200 units.

https://www.kickstarter.com/projects/pluspocket/plus-pocket-the-ultimate-backpack-companion

2024 Mar     New concept & Design

2024 May     Prototype completed

2024 Oct      Kickstarter launch

2024 Nov     Kickstarter ends

2024 Nov     Production & Packaging

2025 Jan     Shipping Start

Media Contact
Company Name: InterDD,LLC
Contact Person: Takami Sueyoshi
Email: Send Email
Phone: 720-412-1250
Address:1001 Wolf Creek Dr.
City: Longmont
State: Colorado
Country: United States
Website: https://www.kickstarter.com/projects/pluspocket/plus-pocket-the-ultimate-backpack-companion

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Alion Corporation Unveils +Pocket Custom: The Stylish and Practical Solution for Effortless Bag Organization

Dumpit Scotland: Premier Waste Disposal Service in Glasgow and Across Scotland

Dumpit Scotland: Premier Waste Disposal Service in Glasgow and Across Scotland

Glasgow, UK – Dumpit Scotland, a SEPA Registered Waste disposal company in Glasgow, is revolutionising the way residents and businesses handle their rubbish and junk removal needs across Glasgow and Scotland. With over 15 years of experience, Dumpit Scotland provides a comprehensive range of waste disposal services that prioritize efficiency, affordability, and environmental responsibility.

Our commitment to eco-friendly practices is demonstrated through our recycling efforts and partnerships with local charities to donate reusable items, reducing landfill contributions. Located in the heart of Glasgow, we serve not only the city but also extend our services to Edinburgh, Falkirk, Ayr, and other regions across Scotland.

Dumpit Scotland offers a wide array of services including household removals, garage and garden waste clearance, office and commercial disposal, and more. Our professional team arrives in pre-arranged two-hour slots, executing same-day service for ultimate convenience. We manage all the heavy lifting, ensuring that your space is left tidy and junk-free.

“Our reliable and transparent waste disposal solutions are designed to meet the unique needs of our customers, whether they are tackling a small household project or a large commercial clearance,” said Rory Friel, Owner of Dumpit Scotland. “Our dedication to quality service and competitive pricing makes us the preferred choice for waste disposal in Glasgow.”

Our flexible pricing system is tailored to reflect the volume and type of waste being removed, starting from £100 + VAT for 1/8 Load. We offer personalized quotes and the convenience of instant estimates through WhatsApp, ensuring transparency and customer satisfaction at every stage.

For more information on our services or to schedule a waste disposal appointment, please contact Dumpit Scotland at 0141 258 1707 or visit Dumpit Scotland.

About Dumpit Scotland

Dumpit Scotland is a leading waste disposal company based in Glasgow, UK. Registered with SEPA, we are committed to providing efficient and environmentally responsible Waste management services in the Glasgow area and across Scotland. Our exceptional reputation for reliability and affordability has been earned through years of dedicated service to our customers.

Media Contact
Company Name: Dumpit Scotland
Contact Person: Rory Friel
Email: Send Email
Phone: 0141 258 1707
Address:50 East Kilbride Road Clarkston
City: Glasgow
Country: Scotland
Website: www.dumpitscotland.co.uk/

Forte Speech & Language Therapy Announces New Transgender Voice Feminization Service

Forte Speech & Language Therapy Announces New Transgender Voice Feminization Service

October 24, 2024 – Forte Speech & Language Therapy is proud to announce the launch of its new transgender voice feminization service, designed to support individuals in their journey toward achieving a voice that aligns with their gender identity. This innovative service aims to provide tailored vocal training, empowering clients to express themselves authentically and confidently.

Forte Speech & Language Therapy

The decision to introduce transgender voice feminization comes in response to the growing need for specialized services within the LGBTQIA+ community. Many transgender women experience gender dysphoria in relation to their voice. This means their voice does not match their gender identity, leading to feelings of discomfort and anxiety. Research indicates that voice is a crucial aspect of personal identity, and for many, achieving a voice that reflects their true self can significantly enhance overall well-being. 

The transgender voice feminization program will include service from Sophie Edwards, a transgender woman herself. Sophie brings her own lived experience, as well as training in the art of voice feminization. The clinic offers transgender voice feminization in Los Angeles via telehealth only. 

The transgender voice feminization program includes an assessment of the client’s current vocal state, characteristics, and goals. From there, treatment will cover various aspects of voice feminization, including pitch, resonance, intonation, smoothness, and more. 

Additionally, the program will address the emotional and psychological aspects of voice transition, providing clients with coping strategies and support throughout their journey. Sophie has been described as kind, patient, empathic, understanding, and, on more than one occasion, “life changing.”

“It’s humbling to be of service to my community like this,” says Sophie. “I know first hand how sharp the sting of dysphoria can be, and it brings me so much joy to be able to help relieve that in others.” 

The launch of the transgender voice feminization service aligns with Forte Speech & Language Therapy’s dedication to providing high-quality, inclusive speech therapy services to diverse populations. 

The clinic’s team of licensed Los Angeles speech therapists takes a therapeutic approach that embraces diversity in all its forms. But it goes far beyond a life philosophy; embracing diversity delivers better therapeutic results. 

“Building on strengths,” adds cofounder Kylie Puckett, “and embracing differences. That’s what it’s all about. These things aren’t ‘bad’ any more than being left handed is ‘bad’. Rather than focusing on problems, we build on strengths. That builds a much stronger sense of self and delivers better results.”

Those interested in services are encouraged to visit the clinic’s website.  

Media Contact

Name of Company or Product: Forte Speech & Language Therapy

Address: Los Angeles, California

Phone: 1 (818) 208-0027

Email: hello@fortespeech.com

Contact Person: Shawn Krumholz, MS, CCC-SLP, and Kylie Puckett, MS, CCC-SLP

URL: https://www.fortespeech.com/

Media Contact
Company Name: Forte Speech & Language Therapy
Contact Person: Shawn Krumholz
Email: Send Email
Phone: 1 (818) 208-0027
City: Los Angeles
State: California
Country: United States
Website: https://www.fortespeech.com/

Future Electronics and Fingerprints Present Secure Biometric Solutions with FPC AllKey

Future Electronics and Fingerprints Present Secure Biometric Solutions with FPC AllKey
Future Electronics has partnered with Fingerprint Cards to present a new webinar on biometric solutions, featuring the innovative FPC AllKey. The session will explore how over 25 years of biometrics expertise has led to this latest, easy-to-integrate product.

Montreal, Canada – October 24, 2024 – Future Electronics, a leading global distributor of electronic components, is proud to announce an upcoming webinar in collaboration with biometrics experts Fingerprint Cards, to showcase a new and exciting biometrics product.

Future Electronics and Fingerprint Cards’ webinar, set for November 7, will introduce attendees to FPC AllKey, a biometric solution designed for seamless integration with host devices. This groundbreaking product is the culmination of over 25 years of biometrics expertise, sensor technology, and industry-leading algorithms. AllKey is offered in both standard and pro variants to meet a range of applications.

During the session, experts from Future Electronics and Fingerprints will discuss the importance of biometric technology in modern security, and provide an overview of the FPC AllKey product family, highlighting its key benefits to integrators and product designers. With built-in software and multiple host interface capabilities, FPC AllKey is ready for immediate deployment across industries, offering unmatched flexibility and security.

Mattias Carlén, Product General Manager at Fingerprints, will lead the presentation, providing insight into the product’s features and how it simplifies biometric security for physical access, cybersecurity, and enterprise applications.

Future Electronics is excited to offer customers a chance to learn from industry leaders and gain firsthand knowledge of the transformative potential of biometrics in today’s security landscape.

For more information about the webinar and to register, visit the link below: https://attendee.gotowebinar.com/register/5376901473767702102?source=LP

About Future Electronics:

Founded in 1968, Future Electronics is a global leader in the electronic components industry. Future Electronics’ award-winning customer service, global supply chain programs and industry-leading engineering design services have made the company a strategic partner of choice.

Headquartered in Montreal, Canada, Future Electronics operates in 159 offices across 44 countries with over 5,000 employees. Its worldwide presence powers the company’s outstanding service and efficient, comprehensive global supply chain solutions. Future Electronics is globally integrated and supported by one IT infrastructure which provides real-time inventory availability and enables fully integrated operations, sales and marketing services worldwide. In 2024, Future became a WT Microelectronics company, now dual-headquartered in both Montreal, Canada and Taipei City, Taiwan.

Future Electronics’ mission is always to Delight the Customer®. For more information visit www.FutureElectronics.com.

Media Contact
Company Name: Future Electronics
Contact Person: Jamie Singerman
Email: Send Email
Phone: 514-694-7710
Address:237 Hymus Boulevard
City: Pointe Claire
State: Quebec
Country: Canada
Website: https://www.futureelectronics.com/